These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9578705)

  • 1. [Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus].
    Varga Z; Vajtai I
    Orv Hetil; 1998 Mar; 139(13):761-5. PubMed ID: 9578705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus.
    Vajtai I; Varga Z; Aguzzi A
    Histopathology; 1996 Aug; 29(2):147-51. PubMed ID: 8872148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The standard isoform of CD44 is preferentially expressed in atypical papillomas and carcinomas of the choroid plexus.
    Varga Z; Vajtai I; Aguzzi A
    Pathol Res Pract; 1996 Dec; 192(12):1225-31. PubMed ID: 9182293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors of the choroid plexus.
    Rickert CH; Paulus W
    Microsc Res Tech; 2001 Jan; 52(1):104-11. PubMed ID: 11135453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA; Morrison AL
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant progression in choroid plexus papillomas.
    Jeibmann A; Wrede B; Peters O; Wolff JE; Paulus W; Hasselblatt M
    J Neurosurg; 2007 Sep; 107(3 Suppl):199-202. PubMed ID: 17918524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study on choroid plexus tumors: immunohistochemical features and argyrophilic nucleolar organizer regions values].
    Shirakawa N; Kannuki S; Matsumoto K
    Noshuyo Byori; 1994; 11(1):99-105. PubMed ID: 8162158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
    Ikota H; Tanaka Y; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
    Beschorner R; Schittenhelm J; Schimmel H; Iglesias-Rozas JR; Herberts T; Schlaszus H; Meyermann R; Wehrmann M
    Hum Pathol; 2006 Jul; 37(7):854-60. PubMed ID: 16784985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
    Albrecht S; Rouah E; Becker LE; Bruner J
    Mod Pathol; 1991 Sep; 4(5):610-4. PubMed ID: 1758873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of prognostic markers in brain tumors.
    Grzybicki DM; Moore SA
    Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining.
    Kato T; Fujita M; Sawamura Y; Tada M; Abe H; Nagashima K; Nakamura N
    Noshuyo Byori; 1996 Nov; 13(2):99-105. PubMed ID: 8958514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of choroid plexus tumors by advanced magnetic resonance spectroscopy.
    Krieger MD; Panigrahy A; McComb JG; Nelson MD; Liu X; Gonzalez-Gomez I; Gilles F; Bluml S
    Neurosurg Focus; 2005 Jun; 18(6A):E4. PubMed ID: 16048290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 expression in choroid plexus neoplasms: an immunohistochemical study.
    Jay V; Ho M; Chan F; Malkin D
    Arch Pathol Lab Med; 1996 Nov; 120(11):1061-5. PubMed ID: 12049110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium.
    Beschorner R; Pantazis G; Jeibmann A; Boy J; Meyermann R; Mittelbronn M; Schittenhelm J
    Acta Neuropathol; 2009 Jun; 117(6):667-75. PubMed ID: 19283393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.